Post by Hot Christian Stocks on Jun 2, 2014 0:15:07 GMT -5
Presenting
Verde Media Group Inc. Announces Signing of MOU With Major Distributor for Beautyject Inc.; Kevin Harrington previously from ABC's Shark Tank To Become Advisor to Beautyject Inc.
LOS ANGELES, May 30, 2014 /PRNewswire/ -- Verde Media Group Inc. (VMGI) is pleased to announce that it has recently entered into a Memorandum of Understanding, through its subsidiary Beautyject Inc., with Power Shark Capital ("PSC") for the sale and distribution of its beauty and cosmetic products throughout North America.
PSC is headed by Jean Jean Pelletier. Mr. Pelletier is an accomplished entrepreneur who has successfully founded and run numerous companies, many of which have been listed on public exchanges in Canada and the U.S. Mr. Pelletier has also acted as an advisor to numerous private and publicly traded companies during his career, and brings with him an expertise in private and public corporate finance, marketing, strategic advising and public and media relations.
Kevin Harrington of PSC will act as an advisor to Beautyject Inc. Mr. Harrington, who starred on the popular television show Shark Tank, is a world-renowned direct marketing expert who is widely recognized as the pioneer and principal architect of the infomercial industry. Mr. Harrington has sold more than $4 Billion worth of products through TV infomercials, commercials and other direct marketing venues.
Mr. Harrington has also authored the best-selling book Act Now: How I Turn Ideas into Million-Dollar Products.
According to the terms of the Memorandum of Understanding, Beautyject has granted to PSC exclusive distribution, sales and marketing of its needleless beauty products for North America. PSC shall be responsible for handling all sales and distribution through infomercials, TV commercials and other direct marketing methods at PSC's cost. "We are very fortunate to be working with the Beautyject team and their unique needleless technology," said Mr. Pelletier, "And we expect to generate tremendous interest as we commence our marketing campaign in the near future."
William Veve, President of Verde Media Group Inc. stated, "Mr. Harrington and Mr. Pelletier have a proven track record in sales and marketing. With their involvement, Beautyject's potential in the North American market will be realized on a fast track."
Beautyject Inc.
Beautyject Inc., ("Beautyject" or "BJI"), incorporated in the State of Nevada, is a majority owned subsidiary of Verde Media. Beautyject is the first company to offer needle-free technology fully adapted to the beauty care and cosmetic markets. The injectors can be used to administer liquid cosmetic products such as Botox, hyaluronic acid, vitamins and a variety of other products to the top layers of the skin through a non-invasive, needle-free, painless delivery system. Previously unavailable for private use, individuals can now administer unique formulations to treat superficial lines, minor skin damage, fine wrinkles, moisture and skin elasticity all at the convenience of their homes with no risk of needle stick injuries and damage to the skin. Practitioners benefit from attracting new clientele, new upsell opportunities for existing treatments such as Botox, precision treatment delivery, increased client satisfaction and increased profitability due to complete emptying of ampoules and a longer shelf life. The company is in advanced discussions with an internationally recognized distribution group that has access to major broadcasting and satellite TV networks for the sale and distribution of its beauty products throughout North America and expects revenues to reach upwards of $25 million in its third year of commercialization.
Beautyject Inc. Retail Sales and Marketing:
In April of this year, VMBD entered the medical and cosmetics industry through its new subsidiary, Beautyject Inc. Beautyject has perpetual rights for North and South America to manufacture, market, distribute and sell the first ever needle-free injection technology specifically adapted to the beauty care and cosmetic markets.
Designed to deliver skin care treatments comfortably, accurately and quickly, without the use of a needle, the company will provide clinical grade skin care products to assist physicians and aestheticians with their procedural skin care needs. In addition, Beautyject will provide over-the-counter products for customers who choose not to have professional treatments.
Commercialization:
Currently, Beautyject has signed an agreement with a successful, internationally recognized distribution group that utilizes far-reaching relationships with major broadcasting and satellite TV networks. The group has a proven track record, having successfully marketed and sold more than $4 billion worth of products to date.
This agreement has been signed and is moving forward with direct sales, marketing and distribution functions for its needle-free kits and products. VMGI will be releasing details about the agreement in the near future.
The anti-aging market was estimated at $274.5 billion in 2013 and is projected to reach a trillion dollars by 2025. With increased demand for multi-feature products with anti-aging and anti-wrinkle properties driving market growth, Beautyject is in line to reach $18.5 million in top line revenues for its year-end 2015.
read CEO letter here
Full DD: stockpycks.com/thread/718/vmgi-verde-media-group?page=1&scrollTo=1934
follow us on:
Follow on Twitter: twitter.com/FusionsPicks
Follow on Facebook: www.facebook.com/fusionspicks
DISCLAIMER fusionspicks.com/
This report/release/advertisement is a commercial advertisement and is for general information purposes only and is neither an offer nor recommendation to buy or sell any security.
The disclaimer is to be read and fully understood before using our site, or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE WELL: Fusionspicks.com employees are not registered as an Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Any compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals should not use this newsletter as the basis for any investment decision.
The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. Factors that could cause actual results to differ include the size and growth of the market for the company's products, the company's ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, pricing pressures, etc. Investing in securities is speculative and carries risk. Past performance does not guarantee future results.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
Non-affiliate third party shareholders or the Profiled Company Issuer (the “Issuer”) compensate us in cash fees. We may independently purchase the security we are promoting in the open market and thereafter conduct further purchase and sale activities of the same security, including during our actual publication of the Information regarding the Issuer. The cash source of our buying activities may be the cash fees that we receive as compensation for the advertisement regarding the Issuer. Our trading activities (as well as those of the third party shareholder) are subject to risks detailed in our full disclaimer. We are in receipt of cash consideration or we sell our securities that we purchased in the open market during our advertising campaign, promotional campaign or in the type electronic communication you are viewing herein pertaining to the Issuer, or at anytime. Our receipt of compensation or our trading activities in the Issuer’s securities is an actual conflict of interest since we are paid cash consideration for the advertising or promotion or Information and we may purchase the securities in the open market and thereafter sell those securities, including during our promotion of the Issuer.
Fusionspicks has been compensated $1000 cash by a non controlling third party for the release of this newsletter and/or other marketing services. Fusionspicks.com does not accept shares as compensation, however we reserve the right to buy or sell shares on the open market at any time, which may positively or negatively affect the price per share. This is not a solicitation to buy or sell any securities. Fusionspicks.com nor any of its affiliates are registered investment advisers or broker dealers.